Literature DB >> 3049338

Volume (weight) loss and blood pressure response following thiazide diuretics.

E D Freis1, D J Reda, B J Materson.   

Abstract

Correlations were made between weight change (as an index of volume loss) and blood pressure (BP) reduction before and after hydrochlorothiazide treatment. A total of 343 patients with mild to moderate hypertension (95-114 mm Hg) received hydrochlorothiazide alone. The diuretic was titrated from 50 to 100 to 200 mg daily as needed until the diastolic BP fell below 90 mm Hg (goal BP) or side effects supervened. Of the 305 patients who completed the 10-week titration period, 65% attained goal BP. The effective dose of hydrochlorothiazide in 52% of these responders was 50 mg/day, and this was associated with weight loss averaging 1.58 kg. An additional 29% achieved goal BP with a similar degree of weight loss, but they required double the dose, or 100 mg/day. The remaining 19% of responders required significantly greater weight reductions averaging 3.14 kg to achieve goal BP, which necessitated hydrochlorothiazide, 200 mg/day. More blacks than whites attained goal BP despite similar degrees of weight loss in the two races. Plasma renin activity was initially higher in whites than in blacks and rose significantly more in blacks and whites requiring the greatest volume losses and the highest dose of hydrochlorothiazide to attain goal BP. Nonresponders had less weight loss than responders. Thus, diuretic dose requirements vary in different patients and are related either to different volume losses in response to a given dose or to different degrees of BP reduction in response to the same volume loss.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049338     DOI: 10.1161/01.hyp.12.3.244

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  12 in total

Review 1.  Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia.

Authors:  Sirirat Reungjui; Thongchai Pratipanawatr; Richard J Johnson; Takahiko Nakagawa
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

2.  Sympathetic stimulation of thiazide-sensitive sodium chloride cotransport in the generation of salt-sensitive hypertension.

Authors:  Andrew S Terker; Chao-Ling Yang; James A McCormick; Nicholas P Meermeier; Shaunessy L Rogers; Solveig Grossmann; Katja Trompf; Eric Delpire; Johannes Loffing; David H Ellison
Journal:  Hypertension       Date:  2014-05-05       Impact factor: 10.190

3.  Obesity as a determinant for response to antihypertensive treatment.

Authors:  R E Schmieder; C Gatzka; H Schächinger; H Schobel; H Rüddel
Journal:  BMJ       Date:  1993-08-28

4.  Baseline Serum Aldosterone-to-Renin Ratio is Associated with the Add-on Effect of Thiazide Diuretics in Non-Diabetic Essential Hypertensives.

Authors:  Chin-Chou Huang; Hsin-Bang Leu; Po-Hsun Huang; Tao-Cheng Wu; Shing-Jong Lin; Jaw-Wen Chen
Journal:  Acta Cardiol Sin       Date:  2013-01       Impact factor: 2.672

Review 5.  Dietary salt restriction and blood pressure in clinical trials.

Authors:  Daniel T Lackland; Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

Review 6.  Race and hypertension. What is clinically relevant?

Authors:  D R Rutledge
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

7.  Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study.

Authors:  Domenic Sica; George L Bakris; William B White; Michael A Weber; William C Cushman; Patrick Huang; Andrew Roberts; Stuart Kupfer
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-06       Impact factor: 3.738

8.  Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blocker.

Authors:  Joseph L Izzo; Joel M Neutel; Tonous Silfani; Robert Dubiel; Findlay Walker
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

9.  The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.

Authors:  Alexandra K Lee; Mark Woodward; Dan Wang; Toshiaki Ohkuma; Bethany Warren; A Richey Sharrett; Bryan Williams; Michel Marre; Pavel Hamet; Stephen Harrap; John W Mcevoy; John Chalmers; Elizabeth Selvin
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

Review 10.  The concept of crosstalk-directed embryological target mining and its application to essential hypertension treatment failures.

Authors:  Alan Alper Sag; Oguzhan Sal; Yagmur Kilic; Emine Meltem Onal; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-02-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.